tirzepatide shortage FDA confirms is still over, gives compounders a grace period FDA Resolves Tirzepatide Shortage: Impact

Are there side effects when using both together Side effects are uncommon at normal doses

Cornea 21:173176

Patients taking GLP-1 receptor agonists such as semaglutide face an important decision when surgery is scheduled: whether to continue, pause, or adjust their medication regimen

The most commonly prescribed GLP-1 medications include: Semaglutide Available as Ozempic (semaglutide) for diabetes and Wegovy (semaglutide) for weight management Tirzepatide Sold as Mounjaro (tirzepatide) for diabetes and Zepbound (tirzepatide) for weight loss Liraglutide Available as Victoza (liraglutide) for diabetes and Saxenda (liraglutide) for weight management Clinical trials demonstrate significant benefits for these medications

A 2006 study by Kossoy et al